RT - Article
SR - Electronic
T1 - 
SP - 2018-03-06
A1 - Zelinska, N., 
A1 - Skorodok, J., 
A1 - Skorodok, J., 
A1 - Malievsky, O., 
A1 - Rosenfeld, R.G., 
A1 - Zadik, Z., 
A1 - Koren, R., 
A1 - Vander, S., 
A1 - Hart, G., 
A1 - Raduk, D., 
YR - 2016
UL - https://repo.bashgmu.ru/publication/704
AB - OPKO Biologics is developing bio-better long-acting
versions of existing therapeutic proteins utilizing a
technology called CTP.